Navigation Links
Scotland Announces New Life Science Leadership and Investments at BIO 2010
Date:4/29/2010

CHICAGO, April 29 /PRNewswire/ --  Scotland will showcase the talent and collaborative spirit that has attracted many of the world's leading pharma and biotech companies to its shores at this year's BIO conference, May 3-6 in Chicago.  Heading into the conference, Scottish Enterprise and sector leaders believe Scottish research and the nation's unique integrated industry approach will continue to fuel life sciences growth, particularly in scientific infrastructure, stem cell therapeutics and translational medicine.

"BIO offers Scotland an extraordinary opportunity to demonstrate our cluster's wealth of scientific talent and our ability to innovate R&D across business, academic and government sectors, ultimately providing an energised, strategic location for life science investment and commercialisation," said Rhona Allison, Senior Director Life Sciences, Scottish Enterprise. "The ability of our sector leaders to collaborate and solve the many challenges facing today's life sciences industry is essential to helping companies safely and effectively deliver new therapies and products to patients."

At BIO, Scotland will feature:

  • Scotland's investment in translational medicine, with Ross McLennan of the Scottish Academic Health Sciences Collaboration (SAHSC) offering insights into how the program, launched last year by the Chief Scientist's Office, enhances Scotland's unique ability to streamline patient-oriented clinical research for pharmaceutical companies through collaboration between NHS Scotland and the nation's universities.
  • New Scottish Stem Cell Network CEO Kevin Price discussing Scotland's position as one of Europe's largest and most highly-regarded stem cell research communities and its role as home to groundbreaking regenerative medicine research such as ReNeuron's stem cell trial for stroke patients.
  • Leadership in creating a best-in-class environment for global innovation exemplified with representation of twenty-two leading Scottish life sciences organisations with support from SE/SDI.
  • Scotland as a location of choice for world-class businesses to collaborate and succeed. The Edinburgh BioQuarter, a major collaboration between Scottish Enterprise, Alexandria Real Estate Equities, Inc., University of Edinburgh and the National Health Service is an offering which exemplifies the excellence of research, clinical and commercial opportunities open to a company  locating in Scotland.  Newly appointed CEO Dr. Michael Capaldi and Chair Dr. Simon Best will discuss investments to make the BioQuarter one of the world's leading hubs for commercialization of life sciences research.

"Scotland is an exciting place to be for life sciences companies and innovators at the moment," said Allison.  "The energy, expertise and unprecedented momentum around our research and commercialisation activities are making Scotland and its collaborative approach an attractive home for cutting-edge investment."

Scotland will also present two interactive panel sessions on Monday, May 3. "From Oligos to Genes to Pathways to Genomes: DNA construction for Synthetic Biology" will cover the emerging field of synthetic biology and Scottish Enterprise's 2.4 million pounds sterling ($3.6 million) Genome Segment Assembly (GSA) research program. "Lost in Translation: Translational R&D as the Road Map to Market" will share global best practices in translational R&D.

Scottish Organizations at BIO

Aquapharm Biodiscovery Limited

Biotech Innovation & Future Health Limited

Borders Technology Management

ChimaeraBio

CXR Biosciences Ltd

GlycoMar Limited

GT Biologics Limited

Ingenza Ltd

Marks & Clerk LLP

Murgitroyd & Company

NovaBiotics Ltd

Ocutec Limited

Sistemic

Solid Form Solutions Ltd

Talent Scotland

University of Aberdeen – Research & Innovation

University of Dundee – Research & Innovation Services

University of Edinburgh – College of Medicine & Veterinary Medicine

University of Edinburgh – Edinburgh Research and Innovation

University of Edinburgh – MRC Centre for Regenerative Medicine

For more information on these companies, please visit Scottish Development International.

For further information on Scotland at BIO, please contact Emily Hyman at 617-520-7094 or ehyman@webershandwick.com.  


'/>"/>
SOURCE Scottish Enterprise; Scottish Development International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
2. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
3. Scotland Launches Chemicals Industry Partnerships To Propel $13 Billion Sector
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology ... announced that an Oncologic Drug Advisory Committee of ... to 0 that the benefit/risk of rituximab/hyaluronidase for ... patients in the proposed indications of follicular lymphoma, ... The FDA action date is June 26, 2017. ...
(Date:3/29/2017)... New Canaan, CT (PRWEB) , ... March 29, 2017 , ... ... of antibiotics and hormones in the world’s food supply through enhancement of the gut ... in the round included Connecticut Innovations , New York-based Sustainable Income Capital Management, ...
(Date:3/29/2017)... /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") ... risk stratification test for breast cancer, via its ... BreastSentry incorporates a blood-based biomarker test with a sophisticated algorithm ... breast cancer.   ... BreastSentry measures the fasting plasma levels of two ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today that Scandinavian ... training plan management for consistent implementation of standards and regulatory requirements across SHL ... to help improve and streamline their training and employee development programs, which are ...
Breaking Biology Technology:
(Date:3/1/2017)... -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics ... has resigned, effective March 3, 2017, as co-Chief ... Treasurer of Aware citing a desire to retire.  Mr. ... the Board of Directors of Aware. ... co-President, General Counsel has been named Chief Executive Officer, ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):